Primary Pulmonary Hypertension Legal Information from PPH Attorneys
The once highly popular diet drug was "too good to be true" for many of the drug patients, leading to serious heart valve problems. In 1997, the Mayo Clinic reported finding heart valve problems in 30% of the Fen Phen users in a study they conducted. Shortly after studies began to expose the adverse health effects that Fen Phen caused, the American Home Products (AHP) prescription drug was pulled from the U.S. market. If you have suffered the health complications as a direct result of using Fen Phen contact us.
Fen Phen was never supported by any studies showing the safety or effectiveness of the drugs, and the FDA never received studies indicating they were safe. AHP owned rights to market and sell pondimin and redux, so they knew about the research and the Adverse Drug Experience reports done on Fen Phen. This makes them liable for the deadly conditions Fen Phen caused. Right now there is a $7.5 billion payout to Fen Phen users, but this amount does not entitle everyone to the proper amount of compensation they should receive. It is not too late to opt-out of the nationwide class action and contact our team of attorneys.
Notice to former Fen Phen users and PPH Patients
Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen are NOT involved in the Nationwide Class Action Settlement Agreement with American Home Products. PPH patients must file independent lawsuits to make legal claims. To learn your legal rights, please contact us and speak with a PPH Lawyer for lawsuit information!
Fen Phen Legal Involvement
September 15, 1997, the prescription diet drug Fen Phen was withdrawn from the market due to the heart valve injuries affecting large quantities of individuals. Before the 1997 removal of Fen Phen from the shelves, individuals who had taken Pondimin or Redux pursued individual lawsuits, as well as class actions against the American Home Products Corporation after medical reports linked the drugs to dangerous forms of valvular heart disease.
Fen Phen Health Issues
Fen Phen has been linked to many different health complications. Initially a Fen Phen patient may have experienced shortness in breath. Because shortness in breath can be attributed to many other things, patients did not feel that was the direct result of taking Fen Phen.
Fen Phen Claims Deadline
There are a large amount of former Fen Phen users that are now suffering heart damage, including valvular heart disease. Symptoms of these serious heart diseases are conspicuous, delaying diagnosis.
The U.S. District Court for the Eastern District of Pennsylvania approved a Nationwide Class Action Settlement Agreement with American Home Products Corporation. Anyone who has taken the diet drugs Fen Phen, Redux, and Pondimin can receive compensation and benefits due to the harmful effects the drugs caused. The monetary compensation that is available to certain former Fen Phen users is more than one million dollars. For individuals not part of the class action they have received even larger compensations.
Our team of experienced attorneys can help recover the damages you are entitled to when you contact us.
Fen Phen Cover Up?
Back in 1997, studies began to show the potentially deadly
effects of Fen Phen. The FDA's key reviewer, Dr. Leo Lutwak, believed American
Home Products knew about the heart problems their diet drug caused long before
its removal from the U.S. market.